@prowiz
Aegros is progressing nicely
In my opinion there's more than 99% CSL buy into Aegros before IPO
CSL stand to lose the most if Aegros succeeds as a plasma competitor or benefit the most from acquiring Aegros prior to IPO
Aegros & CSL are both presenting at upcoming July Protein conference in Brisbane
to think CSL isn't very interested in Aegros as a significant competitor or shrewd acquisition seems far fetched
It's possible that international fractionators are willing to pay massive premium to acquire Aegros - CSL can potentially dominate global plasma markets if it acquires Aegros - or waste an opportunity & risk the rise of Aegros plasma technology
interesting times ahead & can't see CSL allowing Aegros to fall into foreign hands or influence
Ann: Market Update, page-26
-
- There are more pages in this discussion • 94 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$281.85 |
Change
-5.105(1.78%) |
Mkt cap ! $136.4B | |||
| Open | High | Low | Value | Volume |
| $284.41 | $285.00 | $281.69 | $97.06M | 339.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $281.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $281.86 | 9 | 3 |
View Market Depth
| Last trade - 14.56pm 01/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |